Clinical Trials
5 trialsNCT05328024 2026-06-05
IPRICE
Centre Paul Strauss
Recruiting
NCT06731413 2026-06-02
Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
Virginia Commonwealth University
Phase 2 Recruiting
NCT07162506 2026-05-29
DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT07594340 2026-05-22
HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)
Sun Yat-sen University
Phase 3 Recruiting
NCT07595172 2026-05-19
NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer
West China Hospital
Phase 1/2 Recruiting